Showing 1,501 - 1,520 results of 100,213 for search '(( 5 point decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.24s Refine Results
  1. 1501
  2. 1502
  3. 1503
  4. 1504
  5. 1505

    Change in percentage of pO values ≤5 mmHg by Bernardino Clavo (3925)

    Published 2011
    “…</p> During ozone therapy, a decrease in percentage of pO values ≤5 mmHg at each measurement time-point was observed in the tumors of patients: = before ozone therapy; = after session #1 ( = 0.002); = 48 h after session #2 ( = 0.045); = after session #3 ( = 0.033). …”
  6. 1506
  7. 1507

    Lowering Melting Points in Asymmetrically Substituted Salen-Copper(II) Complexes Exhibiting Mesomorphic Behavior. Structure of the Mesogen Cu(5-hexyloxySalen) by Reinhard Paschke (553784)

    Published 2002
    “…In comparison with their symmetrical analogues, unsymmetrically substituted Cu−Salen complexes show mesophases with lowered melting points. For terminally substituted complexes, symmetrical ones (R<sup>1</sup> = R<sup>2</sup>) have only an S<sub>A</sub> phase, while for unsymmetrical alkoxy substitution a monotropic S<sub>E</sub> phase occurs and the melting temperature decreases with no loss in mesophase stability. …”
  8. 1508

    Lowering Melting Points in Asymmetrically Substituted Salen-Copper(II) Complexes Exhibiting Mesomorphic Behavior. Structure of the Mesogen Cu(5-hexyloxySalen) by Reinhard Paschke (553784)

    Published 2002
    “…In comparison with their symmetrical analogues, unsymmetrically substituted Cu−Salen complexes show mesophases with lowered melting points. For terminally substituted complexes, symmetrical ones (R<sup>1</sup> = R<sup>2</sup>) have only an S<sub>A</sub> phase, while for unsymmetrical alkoxy substitution a monotropic S<sub>E</sub> phase occurs and the melting temperature decreases with no loss in mesophase stability. …”
  9. 1509

    Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Stud... by Ken Ohta (727449)

    Published 2015
    “…Commonly reported AEs with tiotropium 5 μg, 2.5 μg and placebo were nasopharyngitis (48.2%, 44.7%, 42.1%), asthma (28.9%, 29.8%, 38.6%), decreased PEFR (15.8%, 7.9%, 21.1%), bronchitis (9.6%, 13.2%, 7.0%), pharyngitis (7.9%, 13.2%, 3.5%) and gastroenteritis (10.5%, 3.5%, 5.3%). …”
  10. 1510

    Decreased Sho levels in ScN2a-Sho cells. by Joel C. Watts (195735)

    Published 2011
    “…(<b>C</b>) Quantification of Sho levels in ScN2a-Sho-1 (<i>n</i> = 10) and ScN2a-Sho-2 (<i>n</i> = 5) subclones revealed a significant decrease of 40–45% compared to the uninfected parental cell line (<i>n</i> = 15) (***<i>P</i><0.001).…”
  11. 1511
  12. 1512
  13. 1513
  14. 1514
  15. 1515
  16. 1516

    Progesterone decreased vanillin-induced responses in the ORNs of p5 mice. by Ninthujah Kanageswaran (683924)

    Published 2016
    “…<p>(A) Representative responses to 100 μM vanillin were obtained from Olfr73 positive ORNs in tissue slices using patch-clamp recordings in a voltage-clamp configuration (V<sub>h</sub> = -56 mV). …”
  17. 1517

    Estradiol decreased vanillin-induced responses in the ORNs of p5 mice. by Ninthujah Kanageswaran (683924)

    Published 2016
    “…<p>(A) Representative responses to 100 μM vanillin from Olfr73 positive ORNs in tissue slices were obtained from patch-clamp recordings set to a voltage-clamp configuration (V<sub>h</sub> = -56 mV). …”
  18. 1518
  19. 1519
  20. 1520